What is the role of propranolol (beta blocker) in treating akathisia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol for Akathisia Treatment

Propranolol is the first-line pharmacological treatment for antipsychotic-induced akathisia, with doses of 10-30 mg two to three times daily being effective in most cases. 1

Understanding Akathisia

Akathisia is characterized by a distressing sense of inner restlessness and inability to remain still, often manifesting as:

  • Constant pacing or physical agitation
  • Subjective feelings of restlessness
  • Inability to sit still or remain in one position

It is commonly misinterpreted as psychotic agitation, anxiety, or worsening of psychiatric symptoms, making it a frequent reason for medication non-adherence.

Evidence for Propranolol in Akathisia

Mechanism and Efficacy

  • Propranolol, a non-selective beta-adrenergic receptor antagonist, has consistently demonstrated effectiveness in treating akathisia
  • Response is typically rapid, often occurring within 24 hours 2
  • Complete remission can be achieved in approximately 64% of cases 2
  • Effective at relatively low doses (30-80 mg/day) 2

Dosing Recommendations

  • Starting dose: 10 mg two to three times daily
  • Can be titrated up to 30 mg three times daily if needed
  • Lower doses may be considered in patients with cardiovascular concerns

Clinical Guidelines Support

The 2025 INTEGRATE guidelines specifically recommend propranolol for akathisia management:

  • "Akathisia can potentially be managed with dose reduction. A switch to quetiapine or olanzapine can also be considered. Alternatively, adjunctive propranolol may be an option (10 mg or up to 30 mg, two to three times daily)." 1

The American Academy of Child and Adolescent Psychiatry also recognizes akathisia as a common extrapyramidal side effect of antipsychotics and notes that it "is often misinterpreted as psychotic agitation or anxiety and is a common reason for medication noncompliance." They further state that "relief has been reported with β-blockers and benzodiazepines." 1

Alternative Options When Propranolol Is Contraindicated

If propranolol is contraindicated (e.g., asthma, bradycardia, heart block):

  • Anticholinergic agents may provide symptomatic relief 3
  • Benzodiazepines can be considered as alternatives 1
  • Serotonin 5-HT2a receptor antagonists (particularly mirtazapine 7.5-15 mg daily) have emerging evidence 3
  • Vitamin B6 (300-600 mg twice daily) has shown comparable efficacy to propranolol in a small trial 4

Important Clinical Considerations

  • Akathisia is often confused with anxiety or agitation, leading to inappropriate management
  • Propranolol's side effects include orthostatic hypotension and bradycardia 3
  • Contraindications include asthma, heart block greater than first degree, and cardiogenic shock
  • Monitor for cardiovascular effects, especially in patients with pre-existing cardiac conditions
  • Propranolol has also shown efficacy in tardive akathisia, a variant that can persist even after antipsychotic discontinuation 5

Treatment Algorithm

  1. First-line: Propranolol 10-30 mg two to three times daily
  2. If ineffective or contraindicated:
    • Consider dose reduction of the causative antipsychotic
    • Switch to an antipsychotic with lower risk of akathisia (quetiapine or olanzapine)
    • Try mirtazapine 7.5-15 mg daily
    • Consider vitamin B6 300-600 mg twice daily
  3. For persistent cases:
    • Combination therapy may be necessary
    • Benzodiazepines can provide symptomatic relief

Propranolol remains the most evidence-based treatment for akathisia, with a favorable side effect profile at the doses typically used for this indication.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.